Literature DB >> 33874925

Impact of preconceptional serum thyroid stimulating hormone values ranging between 2.5 and 4.5 mIU/L on live birth rates following ovulation induction and intrauterine insemination treatment for unexplained infertility.

Lale Susan Karakis1, Huseyin Kiyak2, Berfin Okmen3, Cagdas Ozdemir4, Engin Turkgeldi5.   

Abstract

BACKGROUND: Contrary to overt hypothyroidism, the true impact of subclinical hypothyroidism on fertility has not been well established. This study aimed to investigate whether serum thyroid stimulating hormone (TSH) values between 2.5 and 4.5 mIU/L are associated with lower pregnancy rates compared to TSH levels between 0.3 and 2.5 mIU/L in women undergoing ovulation induction with gonadotropins and intrauterine insemination (IUI) for unexplained infertility.
METHODS: Medical records of couples with unexplained infertility who underwent IUI treatment between January 2013 and December 2018 were reviewed retrospectively. Cycle characteristics and pregnancy outcomes of patients with serum TSH levels between 0.3-2.5 mIU/L and 2.5-4.5 mIU/L were compared. Primary outcome measures were clinical pregnancy and live birth rate. Secondary outcome measures were total dose of gonadotropin administration, duration of ovulation induction and miscarriage rate.
RESULTS: A total of 726 euthyroid women who underwent 1465 cycles of ovulation induction with gonadotropins and IUI were included in the analyses. Patient and cycle characteristics of the two study groups were similar. No statistically significant differences could be detected in the clinical pregnancy (p = 0.74) and live birth rates (p = 0.38) between the two groups. Duration of ovulation induction, total gonadotropin dosage, number of follicles > 17 mm on the trigger day and the miscarriage rates were similar in the two groups.
CONCLUSION: In euthyroid women undergoing ovulation induction with gonadotropins and IUI for unexplained infertility, the range of preconceptional serum TSH values between 2.5 and 4.5 mIU/L is not associated with lower pregnancy rates when compared to TSH levels between 0.3 and 2.5 mIU/L.

Entities:  

Keywords:  Intrauterine insemination; Ovarian stimulation; Ovulation induction; Subclinical hypothyroidism; TSH; Unexplained infertility

Year:  2021        PMID: 33874925     DOI: 10.1186/s12905-021-01299-0

Source DB:  PubMed          Journal:  BMC Womens Health        ISSN: 1472-6874            Impact factor:   2.809


  2 in total

1.  Impact of thyroid autoimmunity in euthyroid women on live birth rate after IUI.

Authors:  D Unuane; B Velkeniers; B Bravenboer; P Drakopoulos; H Tournaye; J Parra; M De Brucker
Journal:  Hum Reprod       Date:  2017-04-01       Impact factor: 6.918

2.  Impact of subclinical hypothyroidism and thyroid autoimmunity on clinical pregnancy rate after intrauterine insemination in euthyroid women.

Authors:  Meryem Kuru Pekcan; A Seval Ozgu-Erdinc; Nafiye Yilmaz
Journal:  JBRA Assist Reprod       Date:  2019-04-30
  2 in total
  2 in total

Review 1.  Thyroid Autoimmunity in Female Infertility and Assisted Reproductive Technology Outcome.

Authors:  Ines Bucci; Cesidio Giuliani; Giulia Di Dalmazi; Gloria Formoso; Giorgio Napolitano
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-26       Impact factor: 6.055

Review 2.  Effect of TSH on oocyte maturation of PCOS patients with normal thyroid function in IVF.

Authors:  Shaoyuan Xu; Cancan Qiang; Ying Zhang; Changjun Zhang
Journal:  Reprod Biol Endocrinol       Date:  2022-09-02       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.